Growth of Healthcare and Pharmaceutical Industry

Cencora's growth strategy is to continue scaling in alignment with the needs of the pharmaceutical industry while simultaneously acquiring new operations and optimizing current U.S. healthcare solutions.

The IQVIA expects the pharma and healthcare industry to grow at a compounded annual rate of 8.2% until 2028. That growth rate is dependent in part to manufacturer price increases. Reasons to believe the healthcare industry will continue to grow are such:
Aging Population - by 2028 the US will have more than 69 million citizens over the age of 65.
New Drugs - Continued research and development of drug and gene therapies as technology pushes this area forward.
Increased Drug Therapy Usage - With the high cost associated with the healthcare industry in the united states there will be more focus than ever on drug therapies for preventative healthcare. Case in point GLP1 memetics like Ozempic for treating the obesity epidemic.

Cencora has also recently acquired Alliance Healthcare EU and is expanding its reach globally.